InvestorsHub Logo
Followers 15
Posts 1555
Boards Moderated 0
Alias Born 02/21/2006

Re: None

Thursday, 04/09/2020 10:08:23 AM

Thursday, April 09, 2020 10:08:23 AM

Post# of 20279
I like the fact that TOMDF has two test kits that are Point of Care (POC). One test for detection of the virus (as well as at the same time testing for influenza A & B), and one test for detection of the antibodies.

They have great sensitivity in their Antibody test which is important and essential going forward as people vary in the strength of antibodies from high to low to none. Currently, antibody plasma is being used to combat Covid-19 and is gaining traction as a treatment.

Lastly, they rapidly modified their business model to accommodate obtaining the test kit distribution rights, setting up to complete the initial testing in USA and partnering in a JV with an established USA vendor.

So bottom-line TOMDF is well positioned to address these World Wide issues / needs.